Guardian Pharmacy Services Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $1.5B+19.1% YoYTTM through 30 Jun 2026
Net Income $65.9MTTM through 30 Jun 2026
Free Cash Flow $94.4MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 21.6% |
| EBITDA Margin | 7.4% |
| Operating Margin | 5.0% |
| Net Margin | 4.5% |
Returns
22.5%ROE
11.9%ROA
33.5%ROIC
Balance Sheet Health
Debt / Equity0.00x
Current Ratio1.38x
Net Debt-$65.6Mnet cash position
Cash & Equivalents$89.8M
Quality Metrics
Altman Z-Score13.66
Piotroski F-Score9 / 9
FCF Margin6.4%
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $1.4B
Dividend
No dividend
Capital Allocation
Capex Intensity0.3%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.